Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

April 01, 1996; Volume 277,Issue 1
  • You have access
    Structure and function of P2 purinocepters.
    G A Weisman, J T Turner and J S Fedan
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 1-9;
  • You have access
    Summary of the ASPET-sponsored Colloquium: Alpha-2 adrenergic receptors: structure, function, and therapeutic implications, October 25-27, 1995.
    S M Lanier, M Lafontan, L E Limbird and H Paris
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 10-16;
  • You have access
    BW755C, a dual lipoxygenase/cyclooxygenase inhibitor, reduces mural platelet and neutrophil deposition and vasoconstriction after angioplasty injury in pigs.
    P Provost and Y Merhi
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 17-21;
  • You have access
    The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL 37344.
    M A Oriowo, H Chapman, D M Kirkham, M V Sennitt, R R Ruffolo and M A Cawthorne
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 22-27;
  • You have access
    Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole.
    M Kinoshita, N Saito, T Noto and H Tamaki
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 28-33;
  • You have access
    Testosterone causes direct relaxation of rat thoracic aorta.
    C E Costarella, J N Stallone, G W Rutecki and F C Whittier
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 34-39;
  • You have access
    Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization.
    R N Iyer and C W Bradberry
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 40-47;
  • You have access
    Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.
    F Brunner, K Schmidt, E B Nielsen and B Mayer
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 48-53;
  • You have access
    Negative inotropic action of denbufylline through interfering with the calcium channel independently of its PDE IV inhibitory activity in guinea pig ventricle papillary muscles.
    F Sanae, S Ohmae, D Kobayashi, K Takag and K Miyamoto
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 54-60;
  • You have access
    The positive inotropic effect and the hydrolysis of phosphoinositide induced by endothelin-3 in rabbit ventricular myocardium: inhibition by a selective antagonist of ET(A) receptors, FR139317.
    M Endoh, I Norota, H T Yang, S Fujita and M Takanashi
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 61-70;
  • You have access
    Effects of napsagatran (Ro 46-6240), a new synthetic thrombin inhibitor and of heparin in a canine model of coronary artery thrombosis: comparison with an ex vivo annular perfusion chamber model.
    S Roux, T Tschopp and H R Baumgartner
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 71-78;
  • You have access
    Placental transfer of valproic acid after liposome encapsulation during in vitro human placenta perfusion.
    M M Barzago, A Bortolotti, F F Stellari, L Diomede, M Algeri, S Efrati, M Salmona and M Bonati
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 79-86;
  • You have access
    Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons.
    J M Witkin, J B Acri, G Wong, S Gleeson and J E Barrett
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 87-96;
  • You have access
    LY353433, a potent, orally effective, long-acting 5-HT(4) receptor antagonist: comparison to cisapride and RS23597-190.
    M L Cohen, W Bloomquist, J M Schaus, D C Thompson, A D Susemichel, D A Calligaro and I Cohen
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 97-104;
  • You have access
    Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation.
    D M Gentile, E S Tomlinson, J L Maggs, B K Park and D J Back
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 105-112;
  • You have access
    Haloperidol and apomorphine differentially affect neuropeptidase activity.
    S M Waters, C S Konkoy and T P Davis
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 113-120;
  • You have access
    Felbamate inhibits dihydropyridine-sensitive calcium channels in central neurons.
    A Stefani, P Calabresi, A Pisani, N B Mercuri, A Siniscalchi and G Bernardi
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 121-127;
  • You have access
    Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits.
    X L Ma, T L Yue, B L Lopez, F C Barone, T A Christopher, R R Ruffolo and G Z Feuerstein
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 128-136;
  • You have access
    Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro -2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland.
    T Inoue, M Domae, K Yamada and T Furukawa
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 137-143;
  • You have access
    Protein kinase C mediates spontaneous tone in the cat lower esophageal sphincter.
    C Hillemeier, K N Bitar, U Sohn and P Biancani
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 144-149;
  • You have access
    Cyanide-induced neurotoxicity involves nitric oxide and reactive oxygen species generation after N-methyl-D-aspartate receptor activation.
    P G Gunasekar, P W Sun, A G Kanthasamy, J L Borowitz and G E Isom
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 150-155;
  • You have access
    Activation of ATP-dependent K+ channels and inhibition of insulin release: effect of BPDZ 62.
    P Lebrun, M H Antoine, R Ouedraogo, C Kane, M Dunne, M Hermann, A Herchuelz, B Masereel, J Delarge, P de Tullio and B Pirotte
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 156-162;
  • You have access
    Mechanism of cardiac inotropy by phenamil, and epithelial sodium channel blocker.
    A Guia, T Chau, D Bose and R Bose
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 163-173;
  • You have access
    d-Sotalol terminates reentry by two mechanisms with different dependence on the duration of the excitable gap.
    H Fei and L H Frame
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 174-185;
  • You have access
    Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors.
    C M O'Hara, A Uhland-Smith, K L O'Malley and R D Todd
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 186-192;
  • You have access
    A1, but not A2A, adenosine receptors modulate electrically stimulated [14C]acetylcholine release from rat cortex.
    R M Broad and B B Fredholm
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 193-197;
  • You have access
    Effects of benztropine on behavioral and toxic effects of cocaine: comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine.
    J B Acri, B K Siedleck and J M Witkin
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 198-206;
  • You have access
    K-7259, a novel dilazep derivative, and d-propranolol attenuate H2O2-induced cell damage.
    N Hoque, A N Hoque, H Hashizume, K Ichihara and Y Abiko
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 207-211;
  • You have access
    Chronic d-amphetamine or methamphetamine produces cross-tolerance to the discriminative and reinforcing stimulus effects of cocaine.
    R L Peltier, D H Li, D Lytle, C M Taylor and M W Emmett-Oglesby
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 212-218;
  • You have access
    Pharmacokinetics of alpha-methyl-L-tryptophan in rhesus monkeys and calculation of the lumped constant for estimating the rate of serotonin synthesis.
    S E Shoaf and B Schmall
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 219-224;
  • You have access
    Effects of cocaine on pulsatile activity of hypothalamic-pituitary-adrenal axis in male rhesus monkeys: neuroendocrine and behavioral correlates.
    Z Sarnyai, N K Mello, J H Mendelson, M Erös-Sarnyai and G Mercer
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 225-234;
  • You have access
    Alpha-1 adrenergic regulation of lactate production by white adipocytes.
    G Faintrenie and A Géloën
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 235-238;
  • You have access
    The validity of spot urine samples for low-level occupational mercury exposure assessment and relationship to porphyrin and creatinine excretion rates.
    M D Martin, T McCann, C Naleway, J S Woods, B G Leroux and A M Bollen
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 239-244;
  • You have access
    Alpha-1 adrenoceptor subtypes involved in mediating adrenergically induced antinatriuresis and antidiuresis in two kidney, one clip Goldblatt and deoxycorticosterone acetate-salt hypertensive rats.
    M A Sattar and E J Johns
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 245-252;
  • You have access
    Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profile.
    O Curet, G Damoiseau, N Aubin, N Sontag, V Rovei and F X Jarreau
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 253-264;
  • You have access
    Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    D Caille, O E Bergis, C Fankhauser, A Gardes, R Adam, T Charieras, A Grosset, V Rovei and F X Jarreau
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 265-277;
  • You have access
    Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain.
    K Kasamo, P Blier and C De Montigny
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 278-286;
  • You have access
    Effects of caffeine and theophylline on acetaminophen pharmacokinetics: P450 inhibition and activation.
    C A Lee, J H Lillibridge, S D Nelson and J T Slattery
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 287-291;
  • You have access
    Phencyclidine metabolite irreversible binding in the rat: gonadal steroid regulation and CYP2C11.
    S R Shelnutt, T M Badger and S M Owens
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 292-298;
  • You have access
    A pharmacological analysis of receptor subtypes and the mechanisms mediating the biphasic response induced by kinins in the rat stomach fundus in vitro.
    D A Cabrini, D J Kyle and J B Calixto
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 299-307;
  • You have access
    The role of specific eicosanoids in mediating the acute narcotic effects of ethanol.
    G I Elmer and F R George
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 308-315;
  • You have access
    Basolateral glutarate transport by isolated S2 segments of rabbit kidney proximal tubules.
    M Kutzer, S Meer, S Haller and J Greven
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 316-320;
  • You have access
    Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.
    M Bourrié, V Meunier, Y Berger and G Fabre
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 321-332;
  • You have access
    Protection of ischemic and reperfused rat myocardium by the nonglucocorticoid 21-aminosteroid U-74389G, a new inhibitor of lipid peroxidation.
    G M Campo, F Squadrito, D Altavilla, G Squadrito, A Avenoso, P Canale, M Ioculano, A Sperandeo and A P Caputi
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 333-340;
  • You have access
    The effects of LY293111Na, a leukotriene B4 receptor antagonist, on the pulmonary neutrophilia and CD11b expression caused by inhalation of a leukotriene B4 aerosol in rhesus monkeys.
    D L Allen, W P Hoffman, P Marder, M R Matchett, P A Leiter, D L Abbott and R K Wolff
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 341-349;
  • You have access
    Skeletal sarcoplasmic reticulum dysfunction induced by reactive oxygen intermediates derived from photoactivated rose bengal.
    T Ishibashi, C I Lee and E Okabe
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 350-358;
  • You have access
    Both dynorphin A(1-17) [Des-Tyr1]dynorphin A(2-17) inhibit adenylyl cyclase activity in rat caudate putamen.
    L H Claye, E M Unterwald, A Ho and M J Kreek
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 359-365;
  • You have access
    The effect of protein binding on the deep tissue penetration and efflux of dermally applied salicylic acid, lidocaine and diazepam in the perfused rat hindlimb.
    S E Cross, Z Wu and M S Roberts
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 366-374;
  • You have access
    Determination and metabolism of dithiol chelating agents. XVII. In humans, sodium 2,3-dimercapto-1-propanesulfonate is bound to plasma albumin via mixed disulfide formation and is found in the urine as cyclic polymeric disulfides.
    R M Maiorino, Z F Xu and H V Aposhian
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 375-384;
  • You have access
    Dose-dependent transitions in nucleus accumbens cell firing and behavioral responding during cocaine self-administration sessions in rats.
    R M Carelli and S A Deadwyler
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 385-393;
  • You have access
    The actions of prostaglandin E2 on potassium currents in rat tail artery vascular smooth muscle cells: regulation by protein kinase A and protein kinase C.
    J Ren, E Karpinski and C G Benishin
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 394-402;
  • You have access
    Budesonide inhibits T cell-initiated epithelial pathophysiology in an in vitro model of inflammation.
    D M McKay, R Brattsand, E Wieslander, M Fung, K Croitoru and M H Perdue
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 403-410;
  • You have access
    Inhibition of rho1 receptor GABAergic currents by alcohols and volatile anesthetics.
    S J Mihic and R A Harris
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 411-416;
  • You have access
    Trimetazidine reverses calcium accumulation and impairment of phosphorylation induced by cyclosporine A in isolated rat liver mitochondria.
    M D Salducci, A M Chauvet-Monges, J P Tillement, E Albengres, B Testa, P Carrupt and A Crevat
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 417-422;
  • You have access
    Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes.
    G N Kumar, A D Rodrigues, A M Buko and J F Denissen
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 423-431;
  • You have access
    Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. IV. Regulation by external Ca++ of alpha-bungarotoxin-sensitive receptor function and of rectification induced by internal Mg++.
    R Bonfante-Cabarcas, K L Swanson, M Alkondon and E X Albuquerque
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 432-444;
  • You have access
    Modulation of sodium channels of rat cerebellar Purkinje neurons by the pyrethroid tetramethrin.
    J H Song and T Narahashi
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 445-453;
  • You have access
    Characterization and modulation of acute tolerance to nicotine in mice.
    M I Damaj, S P Welch and B R Martin
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 454-461;
  • You have access
    Respiratory effects of opioid full and partial agonists in rhesus monkeys.
    A Liguori, W H Morse and J Bergman
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 462-472;
  • You have access
    Prolonged central effects of quinpirole on cardiovascular regulation.
    M van den Buuse, S J Morton, J L Cornish and G A Head
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 473-483;
  • You have access
    Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    E J Bilsky, R N Bernstein, Z Wang, W Sadée and F Porreca
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 484-490;
  • You have access
    Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    E J Bilsky, R N Bernstein, V J Hruby, R B Rothman, J Lai and F Porreca
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 491-501;
  • You have access
    Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban.
    M Kawamura, Y Imura, N Moriya, S Kita, H Fukushi, H Sugihara, K Nishikawa and Z Terashita
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 502-510;
  • You have access
    Uptake of [N-methyl-11C]propionyl-L-carnitine (PLC) in human myocardium.
    V J Cunningham, S D Rosen, H Boyd, S Osman, R J Davenport, R N Gunn, V W Pike and P G Camici
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 511-517;
  • You have access
    Myenteric ganglionic 5-hydroxytryptamine(1P) signal transmission is mediated via Go protein.
    H Y Wang, E Fiorica-Howells, H Pan, M D Gershon and E Friedman
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 518-524;
  • You have access
    Chronic flumazenil alters GABA(A) receptor subunit mRNA expression, translation product assembly and channel function in neuronal cultures.
    T M Zheng, H J Caruncho, W J Zhu, S Vicini, S Ikonomovic, D R Grayson and E Costa
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 525-533;
  • You have access
    Extended in vivo half-life of human soluble complement receptor type 1 fused to a serum albumin-binding receptor.
    S C Makrides, P A Nygren, B Andrews, P J Ford, K S Evans, E G Hayman, H Adari, M Uhlén and C A Toth
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 534-542;
  • You have access
    Effects of wortmannin analogs on bone in vitro and in vivo.
    M Sato, H U Bryant, J A Dodge, H Davis, W F Matter and C J Vlahos
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 543-550;
  • You have access
    Tolerance of hypothalamic beta-endorphin neurons to mu-opioid receptor activation after chronic morphine.
    G Zhang, A H Lagrange, O K Rønnekleiv and M J Kelly
    Journal of Pharmacology and Experimental Therapeutics April 1996, 277 (1) 551-558;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 277, Issue 1
1 Apr 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor
  • Nose-to-Brain Delivery
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics